Products

What will AGI do for Acediasulfone?

This classification denotes an antibiotic with the chemical formula C14H14N2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 30YP2YHH8W, chemically known as n-[4-[(4-aminophenyl)sulfonyl]phenyl]glycine, but which is more commonly know as acediasulfone. European Medicines Agency schedules Acediasulfone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00242MIG. The term ACEDIASULFONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, no. 3 1962, list 4.) As of Q4 2014, ACEDIASULFONE remains the US FDA Preferred Term for this commodity. Acediasulfone bears US NLM identifiers UMLS ID C1958507 and NCI Concept Code C77129. SMILES: C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)NCC(=O)O.

How AGI delivers it

Four ways AGI delivers for Acediasulfone

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Acediasulfone, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Acediasulfone, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Acediasulfone connects

measured by

  • Assay Potencymodel
  • Chemical Puritymodel
  • Melting Pointmodel
  • Residual Solvent Contentmodel